Darby Anderson Sells 733 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Darby Anderson sold 733 shares of the company’s stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total value of $78,416.34. Following the completion of the sale, the executive vice president owned 46,642 shares of the company’s stock, valued at $4,989,761.16. This represents a 1.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Darby Anderson also recently made the following trade(s):

• On Wednesday, February 25th, Darby Anderson sold 396 shares of Addus HomeCare stock. The stock was sold at an average price of $105.36, for a total value of $41,722.56.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $103.53 on Friday. The firm has a market capitalization of $1.92 billion, a P/E ratio of 19.87, a PEG ratio of 1.44 and a beta of 0.91. The business has a 50-day moving average of $109.22 and a 200-day moving average of $112.95. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11. Addus HomeCare Corporation has a 1 year low of $88.96 and a 1 year high of $124.43.

Key Headlines Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
• Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
• Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
• Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
• Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
• Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

Wall Street Analyst Weigh In

A number of analysts recently commented on ADUS shares. BMO Capital Markets assumed coverage on shares of Addus HomeCare in a research report on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price objective for the company. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. Truist Financial set a $135.00 price target on Addus HomeCare and gave the stock a “buy” rating in a research report on Wednesday, January 7th. Stephens cut their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a report on Wednesday. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus price target of $134.33.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Global Retirement Partners LLC grew its holdings in shares of Addus HomeCare by 395.7% during the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after buying an additional 186 shares in the last quarter. Larson Financial Group LLC lifted its stake in Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after acquiring an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC acquired a new position in Addus HomeCare during the 4th quarter worth approximately $29,000. Private Trust Co. NA grew its stake in shares of Addus HomeCare by 65.5% during the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after acquiring an additional 112 shares in the last quarter. Finally, Arax Advisory Partners raised its holdings in shares of Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.